A medical disorder centered on disruptions to the normal sleep/wake cycle and irregular rapid eye movement (REM) sleep patterns, narcolepsy reflects complex interactions between environmental, genetic, and immune system functions.
Narcolepsy Network coordinates upcoming studies on this condition, with one recently announced project centered on pediatric patients with narcolepsy. To date, there is no clinical tool for assessing narcolepsy symptoms among children with the condition and the way it impacts daily functioning. The scope of the project involves children, along with their parent or guardian, discussing narcolepsy symptoms as part of an online focus group.
As reported on Narcolepsy Network, a recently announced clinical trial, the SPARKLE 1501 Study, focuses on narcolepsy with cataplexy (known as narcolepsy type 1). This condition involves strong laughter or emotion resulting in sudden physical collapse while remaining conscious. The focus of this trial is on the safety and efficacy of an investigational drug for patients living with narcolepsy type 1.
